← Back to Patent Explorer
US4294818A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods and materials for detection of multiple sclerosis

Assignee: Molecular Rx Inc
•
Filing: 1979-07-30
•
Granted: 1981-10-13
•
Expires: 1999-07-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods and materials for diagnosis of a multiple sclerosis disease state. Antigenic blood fractions from patients clinically diagnosed for multiple sclerosis are employed to generate heterologous species antibodies. Novel antibody preparations are employed to detect the presence or absence, in a blood sample of a patient to be tested, of immunologically significant components specifically associated with a multiple sclerosis disease state.

Inventors

  • 👤 John McMichael
  • 👤 Ellis L. Kline
  • 👤 James G. Spaulding

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:03
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/564; G01N2800/00; G01N2800/28; G01N2800/285; Y; Y10; Y10S; Y10S436/00; Y10S436/80; Y10S436/804; Y10S436/811; Y10S530/00; Y10S530/806; Y10S530/868

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 53 words
A diagnostic reagent for use in serological determination of the presence of a multiple sclerosis disease state in a human patient, said reagent comprising heterologous species antibodies obtained by means of a heterologous species immune response to exposure to components of a homogenizate of lymphocytes of a human patient suffering from multiple sclerosis.
Claim 2
Dependent Claim 53 words
A diagnostic reagent for use in serological determination of the presence of a multiple sclerosis disease state in a human patient, said reagent comprising heterologous species antibodies obtained by means of a heterologous species immune response to exposure to components of a homogenizate of lymphocytes of a human patient suffering from multiple sclerosis.
Claim 3
Dependent Claim 18 words
A reagent according to claim 1 wherein said antibodies are provided as a component of heterologous species serum.
Claim 4
Dependent Claim 14 words
A reagent according to claim 2 wherein the heterologous species serum is rabbit serum.
Claim 5
Dependent Claim 52 words
A diagnostic method for determining the presence of a multiple sclerosis disease state in a human patient, said method comprising the steps of: (a) forming a mixture of a homogenizate of lymphocytes of said patient with a diagnostic reagent according to claim 1; and (b) monitoring said mixture for an immunological reaction.
Claim 6
Independent Claim 64 words
A method for preparation of antibodies specifically immunologically reactive with components of a homogenizate of lymphocytes of a patient suffering from a multiple sclerosis disease state, said method comprising: (a) administering to an immunolgoically active host animal of heterologous species animal a preparation of homogenized lymphocytes of a human patient having multiple sclerosis; and (b) isolating antibodies from the blood of said host animal.
Claim 7
Independent Claim 64 words
A method for preparation of antibodies specifically immunologically reactive with components of a homogenizate of lymphocytes of a patient suffering from a multiple sclerosis disease state, said method comprising: (a) administering to an immunolgoically active host animal of heterologous species animal a preparation of homogenized lymphocytes of a human patient having multiple sclerosis; and (b) isolating antibodies from the blood of said host animal.
Claim 8
Dependent Claim 42 words
A method according to claim 5 wherein said isolation step includes contacting serum obtained from said host animal with homogenized lymphocytes of a human not having multiple sclerosis, whereby antibodies not specific for multiple sclerosis lymphocytic components are removed from said serum.

References Cited (Backward Citations)

US3864481A Cited
US4113858A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-10-12 1985-04-13 1985-10-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-10-12 1989-04-13 1989-10-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-10-12 1993-04-13 1993-10-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag